Drugs / L-Ascorbate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04800692 | Jun 2021 → Jul 2027 expected | intermittent vascular claudication, peripheral arterial disease | Louis Messina | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-Ascorbate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04800692 ↗ |